IL PROGETTO
Il progetto europeo“bioXclusters – EU Initiative Promoting SME Internationalisation Through Clusters”ha preso il via nel mese di gennaio 2012 e avrà una durata di 24 mesi.
Il progetto è finanziato dalla DG Enterprise della Commissione Europea nell’ambito del bando “Promotion and development of world-class clusters in Europe” e coordinato da ERAI – Agenzia di Sviluppo della regione francese del Rhône Alpes.
bioXclusters punta a rafforzare, attraverso la cooperazione e la condivisione di risorse, la competitività sui mercati globali (3 mercati target: Brasile, Cina e Stati Uniti) delle Piccole e Medie Imprese operanti nel settore delle Scienze della Vita, mettendo a fattor comune le competenze dei 4 territori coinvolti (Catalogna-Spagna, Baviera-Germania, Piemonte-Italia, Rhone Alpes-Francia).
L’obiettivo finale è il raggiungimento della massa critica necessaria per favorire l’internazionalizzazione dei cluster e fornire un supporto forte alle imprese, attraverso competenze mirate e servizi innovativi di alto livello.
Attività:
- Kick-off meeting ufficiale del progetto, 1 e 2 marzo 2012, Lione (Francia)
- Workshop “Brasilian market: opportunities for european actors”, tenuto dal dott. Eduardo Emrich Soares, 13 aprile 2012, Bioindustry Park
Scarica la presentazione » - Missione per le imprese del settore Scienze della Vita a São Paulo e Rio de Janeiro (Brasile),10-14 settembre 2012
Scarica la brochure informativa » - Workshop “Chinese health market: opportunities for European players”, tenuto dal dott. Gao Rong Hui, 31 gennaio 2013, Bioindustry Park
Scarica la presentazione dott. Hui »
Scarica la presentazione dello Studio Regoli e Associati »
PARTNERS
Lyonbiopole, a French healthcare cluster fostering innovation in Auvergne-Rhône-Alpes, a vibrant territory in the heart of Europe. It is the cluster which coordinates bioXclusters plus. Lyonbiopole is the gateway to healthcare innovation in Auvergne Rhône-Alpes Region. The cluster supports ambitious projects and companies in the health sector (including infectious diseases, cancer, nutrition, metabolic diseases). Its aim is to support innovative technologies, products and services for a more personalised medicine to the patient’s benefit.
Biocat coordinates and promotes the healthcare and life sciences sector in Catalonia. Its mission is to dynamise and support the public and private stakeholders that make up the BioRegion, Catalonia’s bioscience cluster, which encompasses companies, research groups and bodies, hospitals, universities, administrations and knowledge- and innovation-transfer support structures.
BioM Biotech Cluster Development GmbH is the coordinating agency of the Bavarian Biotech Cluster for all fields of biotechnology. In addition, BioM coordinates the Munich Biotech Cluster with a focus on pharmaceutical biotechnology and personalised medicine. On behalf of the Bavarian Ministry of Economic Affairs, it serves as the one-stop-shop for biotechnology companies and start-ups in the region as well as the first point of contact for international business partners.
bioPmed is the cluster for life sciences and human health for the Piedmont Region of Italy. Launched in 2009, bioPmed is now the result of the formal aggregation of about 70 players, ranging from large multinational corporations to hi-tech start-ups and innovative SMEs, and including universities and research foundations. They all work together and share a solid strategic plan to create innovation and development in the field of health.